Immune response in mice and cattle after immunization with a Boophilus microplus DNA vaccine containing bm86 gene

被引:11
作者
Ruiz, Lina Maria
Orduz, Sergio
Lopez, Elkin D.
Guzman, Fanny
Patarroyo, Manuel E.
Armengol, Gernma
机构
[1] Corp Invest Biol, Unidad Biotecnol & Control Biol, Medellin, Colombia
[2] Univ Nacl Colombia Medellin, Fac Ciencias, Escuela Biol, Medellin, Colombia
[3] FIDIC, Fdn Inst Inmunol Colombia, Bogota, Colombia
关键词
Boophilus microplus; bm86; gene; DNA immunization; mice; cattle; immune response;
D O I
10.1016/j.vetpar.2006.09.033
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Plasmid pBMC2 encoding antigen Bm86 from a Colombian strain of cattle tick Boophilus microplus, was used for DNA-mediated immunization of BALB/c mice, employing doses of 10 and 50 mu g, delivered by intradermic and intramuscular routes. Anti-Bm86 antibody levels were significantly higher compared to control mice treated with PBS. In the evaluation of immunoglobulin isotypes, significant levels of IgG2a and IgG2b were observed in mice immunized with 50 mu g of pBMC2. Measurement of interleukine (IL) levels (IL-4, IL-5, IL-12(p40)) and interferon-gamma (IFN-gamma) in the sera of mice immunized with pBMC2 indicated high levels of EL-4 and EL-5, although there were also significant levels of IFN-gamma. Mice immunized with pBMC2 showed antigen-specific stimulation of splenocytes according to the incorporation of bromodeoxyuridine and IFN-gamma secretion. In all trials, mice injected intramuscularly with 50 mu g of pBMC2 presented the highest immune response. Moreover, cattle immunized with this DNA vaccine showed antibody production significantly different to the negative control. In conclusion, these results suggest the potential of DNA immunization with pBMC2 to induce humoral and cellular immune responses against B. microplus. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:138 / 145
页数:8
相关论文
共 22 条
  • [1] Immunization of animals: from DNA to the dinner plate
    Babiuk, LA
    van Drunen Littel-van den Hurk, S
    Babiuk, SL
    [J]. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1999, 72 (1-2) : 189 - 202
  • [2] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [3] Use of plasmid DNA for direct gene transfer and immunization
    Davis, HL
    Michel, ML
    Whalen, RG
    [J]. DNA VACCINES: A NEW ERA IN VACCINOLOGY, 1995, 772 : 21 - 29
  • [4] Field studies and cost-effectiveness analysis of vaccination with Gavac™ against the cattle tick Boophilus microplus
    de la Fuente, J
    Rodríguez, M
    Redondo, M
    Montero, C
    García-García, JC
    Méndez, L
    Serrano, E
    Valdés, M
    Enriquez, A
    Canales, M
    Ramos, E
    Boué, O
    Machado, H
    Lleonart, R
    de Armas, CA
    Rey, S
    Rodríguez, JL
    Artiles, M
    García, L
    [J]. VACCINE, 1998, 16 (04) : 366 - 373
  • [5] Bm86 antigen induces a protective immune response against Boophilus microplus following DNA and protein vaccination in sheep
    De Rose, R
    McKenna, RV
    Cobon, G
    Tennent, J
    Zakrzewski, H
    Gale, K
    Wood, PR
    Scheerlinck, JPY
    Willadsen, P
    [J]. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1999, 71 (3-4) : 151 - 160
  • [6] FLOW CYTOMETRIC MEASUREMENT OF TOTAL DNA CONTENT AND INCORPORATED BROMODEOXYURIDINE
    DOLBEARE, F
    GRATZNER, H
    PALLAVICINI, MG
    GRAY, JW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (18): : 5573 - 5577
  • [7] DNA vaccines induce partial protection against Leishmania mexicana
    Dumonteil, E
    Jesus, RSM
    Javier, EO
    del Rosario, GMM
    [J]. VACCINE, 2003, 21 (17-18) : 2161 - 2168
  • [8] Feltquate DM, 1997, J IMMUNOL, V158, P2278
  • [9] Control of ticks resistant to immunization with Bm86 in cattle vaccinated with the recombinant antigen Bm95 isolated from the cattle tick, Boophilus microplus
    García-García, JC
    Montero, C
    Redondo, M
    Vargas, M
    Canales, M
    Boue, O
    Rodríguez, M
    Joglar, M
    Machado, H
    González, IL
    Valdés, M
    Méndez, L
    de la Fuente, J
    [J]. VACCINE, 2000, 18 (21) : 2275 - 2287
  • [10] Geissler M, 1997, J IMMUNOL, V159, P5107